|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PARRIS N. GLENDENING, Governor
|
|
|
|
|
S.B. 386
|
|
|
|
|
|
|
|
|
|
|
(b) Unless authorized to practice occupational therapy under this title, a
person may not use the CREDENTIALING abbreviation "O.T."[, "O.T.R.",] or any other
words, letters, or symbols with the intent to represent that the person practices
occupational therapy.
10-403.
(a) Unless authorized to practice limited occupational therapy under this title,
a person may not represent to the public by title, by description of services, methods,
or procedures, or otherwise, that the person is authorized to practice limited
occupational therapy in this State.
(b) Unless authorized to practice limited occupational therapy under this title,
a person may not use the CREDENTIALING abbreviation "O.T.A."[, "C.O.T.A.",] or any
other words, letters, or symbols with the intent to represent that the person practices
limited occupational therapy.
SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect
October 1, 2000.
|
|
|
|
|
|
|
|
May 18, 2000
The Honorable Thomas V. Mike Miller, Jr.
President of the Senate
State House
Annapolis MD 21401
Dear Mr. President:
In accordance with Article II, Section 17 of the Maryland Constitution, I have today
vetoed Senate Bill 386 - Health Benefit Plans - Coverage for Hair Prostheses for
Hair Loss Resulting from Chemotherapy or Radiation Treatment for Cancer.
This bill requires health insurers, nonprofit health service plans and HMOs to cover
the cost of hair prostheses for individuals whose hair loss results from chemotherapy
or radiation treatment for cancer. The cost of a prosthesis may not exceed $350.
House Bill 22, which was passed by the General Assembly and signed by me on May
11, 2000, accomplishes the same purpose. Therefore, it is not necessary for me to sign
Senate Bill 386.
Sincerely,
Parris N. Glendening
Governor
Senate Bill No. 386
AN ACT concerning
Health Benefit Plans - Coverage for Chemotherapy Hair Prostheses for Hair
Loss Resulting from Chemotherapy or Radiation Treatment for Cancer
|
|
|
|
|
|
|
|
- 3855 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|